Viewing StudyNCT01524978



Ignite Creation Date: 2024-05-06 @ 12:13 AM
Last Modification Date: 2024-10-26 @ 10:46 AM
Study NCT ID: NCT01524978
Status: COMPLETED
Last Update Posted: 2017-11-20
First Post: 2012-01-27

Brief Title: A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-04-12
Start Date Type: ACTUAL
Primary Completion Date: 2016-10-28
Primary Completion Date Type: ACTUAL
Completion Date: 2016-10-28
Completion Date Type: ACTUAL
First Submit Date: 2012-01-27
First Submit QC Date: January 31 2012
Study First Post Date: 2012-02-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-11-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-10-17
Last Update Post Date: 2017-11-20
Last Update Post Date Type: ACTUAL